3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
4
Lung Neoplasms
4
Oropharyngeal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Mouth Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Colorectal Neoplasms
2
Carcinoma
2
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stage II Prostate Adenocarcinoma
1
Sarcoma, Ewing
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Prostate Adenocarcinoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Nasopharyngeal Carcinoma
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoid Interstitial Pneumonia
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Interventions
Standard of Care
1
Specimen Handling
1
Practice Guidelines as Topic
1
Magnetic Resonance Spectroscopy
1
Laparoscopy
1
Hyperthermic Intraperitoneal Chemotherapy
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Peritoneal Neoplasms
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT07001748
2026-05-15
STOPGAP II
Eastern Cooperative Oncology Group
Phase 2/3
Recruiting
148 enrolled